AGENUS INC Increase (Decrease) in Contract with Customer, Liability
AGENUS INC (AGEN) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-07
- AGENUS INC increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $0.00.
- AGENUS INC increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AGENUS INC increase (decrease) in contract with customer, liability for fiscal 2025 was $1.00K, a 95.00% decline from fiscal 2024.
- AGENUS INC increase (decrease) in contract with customer, liability for fiscal 2024 was $20.00K.
- AGENUS INC increase (decrease) in contract with customer, liability for fiscal 2023 was -$12.25M.
- AGENUS INC increase (decrease) in contract with customer, liability for fiscal 2022 was -$10.37M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $26.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $26.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.00K 10-K · filed 2026-03-16 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $26.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.00K 10-Q · filed 2025-11-10 | $28.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.00K 10-Q · filed 2026-08-07 | $28.00K derived: sum of 3 quarters · filed 2026-08-07 | $30.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | -$25.00K 10-Q · filed 2026-05-11 | $2.00K derived: sum of 2 quarters · filed 2026-05-11 | $4.00K derived: sum of 3 quarters · filed 2026-05-11 | -$1.00K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $29.00K derived: sum of 2 quarters · filed 2026-03-16 | $24.00K derived: sum of 3 quarters · filed 2026-03-16 | $20.00K 10-K · filed 2026-03-16 | |||
| 2024-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.00K derived: sum of 2 quarters · filed 2025-11-10 | -$7.00K 10-Q · filed 2025-11-10 | -$4.99M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$9.00K 10-Q · filed 2025-08-11 | -$4.99M derived: sum of 3 quarters · filed 2026-03-16 | -$7.82M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-03-31 | -$4.00K 10-Q · filed 2025-05-12 | -$4.98M derived: sum of 2 quarters · filed 2026-03-16 | -$7.81M derived: sum of 3 quarters · filed 2026-03-16 | -$9.87M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2023-12-31 | -$4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$7.81M derived: sum of 2 quarters · filed 2026-03-16 | -$9.87M derived: sum of 3 quarters · filed 2026-03-16 | -$12.25M 10-K · filed 2026-03-16 | |||
| 2023-09-30 | -$2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$4.89M derived: sum of 2 quarters · filed 2024-11-12 | -$7.27M 10-Q · filed 2024-11-12 | -$9.78M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-06-30 | -$2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.44M 10-Q · filed 2024-08-08 | -$6.95M derived: sum of 3 quarters · filed 2025-03-17 | -$11.52M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-03-31 | -$2.38M 10-Q · filed 2024-05-07 | -$4.89M derived: sum of 2 quarters · filed 2025-03-17 | -$9.47M derived: sum of 3 quarters · filed 2025-03-17 | -$11.40M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2022-12-31 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$7.08M derived: sum of 2 quarters · filed 2025-03-17 | -$9.02M derived: sum of 3 quarters · filed 2025-03-17 | -$10.37M 10-K · filed 2025-03-17 | |||
| 2022-09-30 | -$4.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$6.51M derived: sum of 2 quarters · filed 2023-11-09 | -$7.86M 10-Q · filed 2023-11-09 | -$9.30M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$3.28M 10-Q · filed 2023-08-08 | -$4.73M derived: sum of 3 quarters · filed 2024-03-14 | -$22.63M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | -$1.35M 10-Q · filed 2023-05-09 | -$2.79M derived: sum of 2 quarters · filed 2024-03-14 | -$20.69M derived: sum of 3 quarters · filed 2024-03-14 | -$22.09M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$19.34M derived: sum of 2 quarters · filed 2024-03-14 | -$20.75M derived: sum of 3 quarters · filed 2024-03-14 | -$21.83M 10-K · filed 2024-03-14 | |||
| 2021-09-30 | -$17.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$19.30M derived: sum of 2 quarters · filed 2022-11-08 | -$20.38M 10-Q · filed 2022-11-08 | -$23.11M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.49M 10-Q · filed 2022-08-09 | -$5.21M derived: sum of 3 quarters · filed 2023-03-16 | -$9.35M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-03-31 | -$1.09M 10-Q · filed 2022-05-10 | -$3.81M derived: sum of 2 quarters · filed 2023-03-16 | -$7.95M derived: sum of 3 quarters · filed 2023-03-16 | -$10.68M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2020-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$6.87M derived: sum of 2 quarters · filed 2023-03-16 | -$9.59M derived: sum of 3 quarters · filed 2023-03-16 | -$11.46M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$6.87M derived: sum of 2 quarters · filed 2021-11-09 | -$8.74M 10-Q · filed 2021-11-09 | -$17.39M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$4.60M 10-Q · filed 2021-08-09 | -$13.25M derived: sum of 3 quarters · filed 2022-03-01 | -$3.50M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$1.88M 10-Q · filed 2021-05-07 | -$10.53M derived: sum of 2 quarters · filed 2022-03-01 | -$778.00K derived: sum of 3 quarters · filed 2022-03-01 | -$4.60M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$8.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.10M derived: sum of 2 quarters · filed 2022-03-01 | -$2.73M derived: sum of 3 quarters · filed 2022-03-01 | $53.90M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $9.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $5.92M derived: sum of 2 quarters · filed 2020-11-09 | $62.55M 10-Q · filed 2020-11-09 | $63.22M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-06-30 | -$3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $52.80M 10-Q · filed 2020-08-10 | $53.47M derived: sum of 3 quarters · filed 2021-03-16 | $53.21M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2019-03-31 | $56.63M 10-Q · filed 2020-05-11 | $57.30M derived: sum of 2 quarters · filed 2021-03-16 | $57.03M derived: sum of 3 quarters · filed 2021-03-16 | $56.70M derived: sum of 4 quarters · filed 2021-03-16 | |||
| 2018-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $405.00K derived: sum of 2 quarters · filed 2021-03-16 | $76.00K derived: sum of 3 quarters · filed 2021-03-16 | -$397.00K 10-K · filed 2021-03-16 | -$397.38K 10-K · filed 2019-03-18 | ||
| 2018-09-30 | -$262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$591.00K derived: sum of 2 quarters · filed 2019-11-07 | -$1.06M 10-Q · filed 2019-11-07 | -$1.06M 10-Q · filed 2018-11-07 | -$1.78M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-06-30 | -$329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$802.00K 10-Q · filed 2019-08-09 | -$802.11K 10-Q · filed 2018-08-09 | -$1.52M derived: sum of 3 quarters · filed 2020-03-16 | -$2.41M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-03-31 | -$473.00K 10-Q · filed 2019-05-10 | -$1.19M derived: sum of 2 quarters · filed 2020-03-16 | -$2.08M derived: sum of 3 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | -$715.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$1.60M derived: sum of 2 quarters · filed 2020-03-16 | -$2.72M 10-K · filed 2020-03-16 | -$2.72M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | -$888.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.01M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$1.12M 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | -$3.94M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |